Sanara MedTech Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
SMTI on Nasdaq
Location
1200 Summit Ave, Suite 414, Fort Worth, TX

There are no Buy or Sell transactions made by insiders since 4/22/2024

Sanara MedTech Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ronald T. Nixon Chief Executive Officer, Director, 10%+ Owner $40M Feb 25, 2025
James W. Stuckert Director, 10%+ Owner $37.7M Jun 12, 2024
Seth D. Yon Pres. & Ch. Commercial Officer $2.29M Apr 7, 2025
Zachary B. Fleming Chief Executive Officer $1.9M Mar 7, 2024
Christopher A. Morrison President - Telehealth Svcs. $1.15M Jan 1, 2022
Michael D. McNeil Ch. Acct. & Ch. Admin. Officer $1.07M Apr 10, 2025
J. Michael Carmena Principal Executive Officer, Director $909K Dec 22, 2021
Ann Beal Salamone Director $775K Jun 12, 2024
Robert A. DeSutter Director $758K Jun 12, 2024
Kenneth E. Thorpe Director $696K Jul 7, 2022
Sara N. Ortwein Director $683K Jun 12, 2024
Eric D. Tanzberger Director $548K Jun 12, 2024
Roszell Mack III Director $510K Jun 12, 2024
Shawn M. Bowman Pres. - Strat. Partnerships $471K Dec 2, 2022
Rebecca E. McMahon President - R&D $394K Mar 17, 2023
Jacob A. Waldrop Chief Operating Officer $338K Apr 15, 2025
Eric D. Major Director $238K Jun 12, 2024
Elizabeth B. Taylor Chief Financial Officer $210K Feb 25, 2025
Suresh V. Muppalla Pres & CEO, Tissue Health Plus $103K Apr 7, 2025
Keith G. Myers Director $76.9K Nov 11, 2024

Recent Insider Transactions by Companies or Individuals for Sanara MedTech Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.